These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8286743)

  • 1. Alterations of p53 and c-myc in the clonal evolution of malignant lymphoma.
    Chang H; Benchimol S; Minden MD; Messner HA
    Blood; 1994 Jan; 83(2):452-9. PubMed ID: 8286743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines.
    Chang H; Blondal JA; Benchimol S; Minden MD; Messner HA
    Leuk Lymphoma; 1995 Sep; 19(1-2):165-71. PubMed ID: 8574164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.
    Cesarman E; Chadburn A; Inghirami G; Gaidano G; Knowles DM
    Blood; 1992 Dec; 80(12):3205-16. PubMed ID: 1361372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt's lymphoma.
    Gutiérrez MI; Bhatia K; Cherney B; Capello D; Gaidano G; Magrath I
    Ann Oncol; 1997 Oct; 8(10):987-94. PubMed ID: 9402172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc.
    Scarpa A; Moore PS; Rigaud G; Inghirami G; Montresor M; Menegazzi M; Todeschini G; Menestrina F
    Br J Haematol; 1999 Oct; 107(1):106-13. PubMed ID: 10520030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOXD3 Up-regulating KDM5C Promotes Malignant Progression of Diffuse Large B-Cell Lymphoma by Decreasing p53 Expression.
    Cui Y; Lv C; Wen Y; Zhao D; Yang Y; Qiu H; Wang C
    Balkan Med J; 2022 Jan; 39(1):30-38. PubMed ID: 34928233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of tumor suppressor genes and deregulation of the c-myc gene in urothelial cancer cell lines.
    Grimm MO; Jürgens B; Schulz WA; Decken K; Makri D; Schmitz-Dräger BJ
    Urol Res; 1995; 23(5):293-300. PubMed ID: 8839385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation.
    Inghirami G; Macri L; Cesarman E; Chadburn A; Zhong J; Knowles DM
    Blood; 1994 Jun; 83(12):3581-90. PubMed ID: 8204884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive production of the interleukins IL-5 and IL-6 by the lymphoma cell line OCI-Ly 17 derived from a patient with malignant lymphoma and hypereosinophilia.
    Chang H; Jamal N; Wang XH; Minden MD; Messner HA
    Leuk Lymphoma; 1992 Sep; 8(1-2):97-107. PubMed ID: 1493476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines.
    Cheng J; Haas M
    Mol Cell Biol; 1990 Oct; 10(10):5502-9. PubMed ID: 2144611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
    Korkolopoulou P; Oates J; Kittas C; Crocker J
    J Clin Pathol; 1994 Jan; 47(1):9-14. PubMed ID: 7907610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexa.
    Chen PM; Chiou TJ; Yu IT; Fan FS; Chu CJ; Kao SC; Wang WS; Liu JH; Hsu WM; Yang MH; Chao TC; Tai CJ; Hsiao LT; Lin JT; Yen CC
    Leuk Lymphoma; 2001 Jun; 42(1-2):207-14. PubMed ID: 11699208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 alterations in human leukemia-lymphoma cell lines: in vitroartifact or prerequisite for cell immortalization?
    Drexler HG; Fombonne S; Matsuo Y; Hu ZB; Hamaguchi H; Uphoff CC
    Leukemia; 2000 Jan; 14(1):198-206. PubMed ID: 10637496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240.
    Wiman KG; Magnusson KP; Ramqvist T; Klein G
    Oncogene; 1991 Sep; 6(9):1633-9. PubMed ID: 1923530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the p53 gene in human choriocarcinoma cell lines.
    Yaginuma Y; Yamashita T; Takuma N; Katayama H; Ishikawa M
    Br J Cancer; 1995 Jan; 71(1):9-12. PubMed ID: 7819056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line.
    Wang Y; Ramqvist T; Szekely L; Axelson H; Klein G; Wiman KG
    Cell Growth Differ; 1993 Jun; 4(6):467-73. PubMed ID: 8373731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 protein accumulation and gene mutations in human glioma cell lines.
    Anker L; Ohgaki H; Ludeke BI; Herrmann HD; Kleihues P; Westphal M
    Int J Cancer; 1993 Dec; 55(6):982-7. PubMed ID: 8253536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy.
    Asai A; Miyagi Y; Sugiyama A; Gamanuma M; Hong SH; Takamoto S; Nomura K; Matsutani M; Takakura K; Kuchino Y
    J Neurooncol; 1994; 19(3):259-68. PubMed ID: 7807177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms.
    Sugimoto KJ; Kawamata N; Sakajiri S; Oshimi K
    Jpn J Cancer Res; 2002 Nov; 93(11):1270-7. PubMed ID: 12460470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
    García-Sanz R; Vargas Montero M; Gonzalez Díaz M; del Carmen M; Santos C; Balanzategui Echevarria A; Flores Corral T; Hernández Martín JM; Caballero Barrigón MD; San Miguel JF
    Haematologica; 1998 Mar; 83(3):209-16. PubMed ID: 9573674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.